{"data":{"id":"us-mt/50-32-225","jurisdiction":"us-mt","citation":"50-32-225","heading":"Criteria for placement of drug in Schedule III.","body":"The board shall place a drug in Schedule III if it finds that:\n(1) the drug has a potential for abuse less than the drugs listed in Schedules I and II;\n(2) the drug has currently accepted medical use in treatment in the United States; and\n(3) abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.","path":["TITLE 50. HEALTH AND SAFETY","CHAPTER 32. CONTROLLED SUBSTANCES","Part 2. Scheduling of Dangerous Drugs"],"source_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0250/0500-0320-0020-0250.html","current_through":"Montana Code Annotated 2025","vintage":"","retrieved_at":"2026-09-14T04:56:24Z","sha256":"df4bfc90a59ebe097e59f628aa4f570c5c4c1f149468a7b47eafc0887b81d0f9","source_id":"us-mt","stale":false,"prev":"us-mt/50-32-224","next":"us-mt/50-32-226"},"notice":"GroundRules: Original legal text. Not legal advice."}